Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Human ROR1 Protein, full ECD, Fc Tag (MALS verified) DMF Filed, 200 µg  

Recombinant Human ROR1 Protein, full ECD, Fc Tag (MALS verified) DMF Filed, 200 µg

Recombinant Human / Cynomolgus / Rhesus macaque ROR1 /NTRKR1 Protein, full extracellular domain, (Gln 30 - Glu 403), produced in human 293 cells (HEK293), Fc tag (MALS verified) DMF Filed

Synonym: Recombinant human Protein, ROR1, NTRKR1

More details

RO1-H5250-200

Availability: within 7 days

325,00 €

Background
Tyrosine-protein kinase transmembrane receptor ROR1 is also known as Neurotrophic tyrosine kinase, receptor-related 1 (NTRKR1), which belongs to the protein kinase superfamily or tyr protein kinase family or ROR subfamily. ROR1 contains 1 FZ (frizzled) domain, 1 Ig-like C2-type (immunoglobulin-like) domain, 1 kringle domain, 1 protein kinase domain. ROR1 is expressed at high levels during early embryonic development. The expression levels drop strongly around day 16 and there are only very low levels in adult tissues. Isoform Short is strongly expressed in fetal and adult CNS and in a variety of human cancers, including those originating from CNS or PNS neuroectoderm. ROR1 could interact with casein kinase 1 epsilon (CK1e) to activate phosphoinositide 3-kinase-mediated AKT phosphorylation and cAMP-response-element-binding protein (CREB), which was associated with enhanced tumor-cell growth.

Source
Recombinant Human / Cynomolgus / Rhesus macaque ROR1, Fc Tag (RO1-H5250) is expressed from human 293 cells (HEK293). It contains AA Gln 30 - Glu 403 (Accession # Q01973-1). In the region Gln 30 - Glu 403, the AA sequence of Human, Cynomolgus and Rhesus macaque ROR1 are homologus.
Predicted N-terminus: Gln 30

Molecular Characterization
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 68.6 kDa. The protein migrates as 79-95 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin
Less than 1.0 EU per μg by the LAL method.

Purity
>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.

Formulation
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.

Reconstitution
See Certificate of Analysis for details of reconstitution instruction and specific concentration.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Bioactivity
Please refer to product data sheet.

Clinical and Translational Updates

(1) "Correction: ROR1-targeting switchable CAR-T cells for cancer therapy"
Peng, Nerreter, Mestermann et al
Oncogene (2024)
(2) "Retraction: Ectopic expression of ROR1 prevents cochlear hair cell loss in guinea pigs with noise-induced hearing loss"
J Cell Mol Med (2024) 28 (4), e18169
(3) "Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative Breast Cancer"
Limsakul, Choochuen, Jungrungrueang et al
Int J Mol Sci (2024) 25 (3)
Showing 1-3 of 551 papers.

The following products could also be interesting for you: